Immucell Corp (ICCC) –
-
Form 8-K IMMUCELL CORP /DE/ For: Mar 04
-
Immucell Corp (ICCC) Reports Q4 Loss of $0.15
-
Form 8-K IMMUCELL CORP /DE/ For: Feb 27
-
Form 8-K IMMUCELL CORP /DE/ For: Feb 22
-
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
-
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
-
Form 8-K IMMUCELL CORP /DE/ For: Jan 08
-
Immucell Corp (ICCC) Announces Preliminary, Unaudited Sales Results for Q4 2023
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023
-
Form 8-K IMMUCELL CORP /DE/ For: Nov 14
-
Immucell Corp (ICCC) Reports Q3 Loss of $0.12
-
Form 10-Q IMMUCELL CORP /DE/ For: Sep 30
-
Form 8-K IMMUCELL CORP /DE/ For: Nov 13
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023
-
Form 8-K IMMUCELL CORP /DE/ For: Oct 05
-
Immucell Corp (ICCC) Reports Preliminary, Unaudited Sales Results for Q3 2023
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023
-
Form 4 IMMUCELL CORP /DE/ For: Sep 06 Filed by: Tomsche David Scott
-
Form 4 IMMUCELL CORP /DE/ For: Jun 28 Filed by: Gathagan Bryan K.
-
Immucell Corp (ICCC) Announces Submission of CMC Technical Section to the FDA
-
ImmuCell Announces Submission of CMC Technical Section to the FDA
-
Immucell Corp (ICCC) Reports Q2 EPS of $0.18
-
Form 10-Q IMMUCELL CORP /DE/ For: Jun 30
-
Form 8-K IMMUCELL CORP /DE/ For: Aug 10
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023
-
Form 8-K IMMUCELL CORP /DE/ For: Jul 17
-
Form S-8 IMMUCELL CORP /DE/
-
Immucell Corp (ICCC) Reports Prelim Q2 Sales of $3.53M
-
Form 8-K IMMUCELL CORP /DE/ For: Jul 11
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023
-
Form 8-K IMMUCELL CORP /DE/ For: Jun 28
-
ImmuCell Announces Change in Timing of Anticipated FDA Submission
-
Form 3 IMMUCELL CORP /DE/ For: Jun 16 Filed by: Gathagan Bryan K.
-
Immucell Corp (ICCC) Appoints Bryan K. Gathagan to its Board
-
ImmuCell Appoints Bryan K. Gathagan to Board of Directors
-
Form 8-K IMMUCELL CORP /DE/ For: Jun 15
-
Immucell Corp (ICCC) Announces Approval of Principal Terms of a $3M Debt Facility
-
ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility
-
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
-
Immucell Corp (ICCC) Reports Q1 Loss of $0.30
-
Form 10-Q IMMUCELL CORP /DE/ For: Mar 31
-
Form 8-K IMMUCELL CORP /DE/ For: May 11
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023
-
Form ARS IMMUCELL CORP /DE/ For: Dec 31
-
Form DEF 14A IMMUCELL CORP /DE/ For: Jun 15
-
Form PRE 14A IMMUCELL CORP /DE/ For: Apr 18
-
Immucell Corp (ICCC) Announces Preliminary, Unaudited Sales Results for Q1 2023
Back to ICCC Stock Lookup